Avastin Approval History
- FDA approved: Yes (First approved February 26th, 2004)
- Brand name: Avastin
- Generic name: bevacizumab
- Company: Genentech, Inc.
- Treatment for: Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Glioblastoma Multiforme, Renal Cell Carcinoma, Cervical Cancer
Avastin (bevacizumab) is a recombinant humanized monoclonal IgG1 antibody for the treatment of metastatic colorectal cancer, non-small cell lung cancer, HER2-negative breast cancer, glioblastoma, renal cell carcinoma, and cervical cancer.
Development History and FDA Approval Process for Avastin
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.